AOA Dx Submits CLIA Application and Opens Waitlist for Omira™ OC, the Blood Test Built for Women With Ovarian Cancer Symptoms
Study demonstrates that integrating lipids, metabolites, and proteins reveals coordinated molecular signatures missed by traditional single omic tests.